Insider Buying: Natus Medical Incorporated (BABY) Insider Buys $135,920.00 in Stock

Natus Medical Incorporated (NASDAQ:BABY) insider James B. Hawkins acquired 4,000 shares of Natus Medical stock in a transaction dated Thursday, June 15th. The shares were purchased at an average price of $33.98 per share, for a total transaction of $135,920.00. Following the completion of the transaction, the insider now directly owns 578,023 shares in the company, valued at approximately $19,641,221.54. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

James B. Hawkins also recently made the following trade(s):

  • On Wednesday, May 31st, James B. Hawkins acquired 6,000 shares of Natus Medical stock. The shares were purchased at an average price of $33.81 per share, for a total transaction of $202,860.00.

Natus Medical Incorporated (NASDAQ BABY) traded up 3.53% during trading on Tuesday, reaching $36.70. The company had a trading volume of 161,356 shares. The company has a market capitalization of $1.19 billion, a PE ratio of 35.29 and a beta of 0.95. Natus Medical Incorporated has a one year low of $33.15 and a one year high of $44.39. The firm’s 50 day moving average is $34.70 and its 200 day moving average is $36.78.

Natus Medical (NASDAQ:BABY) last issued its quarterly earnings data on Wednesday, April 26th. The medical equipment provider reported $0.30 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.33 by $0.03. Natus Medical had a return on equity of 12.70% and a net margin of 8.17%. The company had revenue of $124.70 million for the quarter, compared to the consensus estimate of $122.45 million. During the same period in the previous year, the firm earned $0.34 earnings per share. The company’s revenue was up 42.8% compared to the same quarter last year. On average, equities research analysts predict that Natus Medical Incorporated will post $1.70 earnings per share for the current year.

Insider Buying and Selling by Quarter for Natus Medical (NASDAQ:BABY)

WARNING: “Insider Buying: Natus Medical Incorporated (BABY) Insider Buys $135,920.00 in Stock” was published by Ticker Report and is the sole property of of Ticker Report. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.tickerreport.com/banking-finance/2655758/insider-buying-natus-medical-incorporated-baby-insider-buys-135920-00-in-stock.html.

A number of large investors have recently modified their holdings of BABY. Piedmont Investment Advisors LLC boosted its stake in shares of Natus Medical by 142.8% in the first quarter. Piedmont Investment Advisors LLC now owns 41,032 shares of the medical equipment provider’s stock valued at $1,611,000 after buying an additional 24,132 shares during the last quarter. Lyon Street Capital LLC boosted its stake in shares of Natus Medical by 65.6% in the first quarter. Lyon Street Capital LLC now owns 755,167 shares of the medical equipment provider’s stock valued at $29,640,000 after buying an additional 299,151 shares during the last quarter. AQR Capital Management LLC boosted its stake in shares of Natus Medical by 3.4% in the first quarter. AQR Capital Management LLC now owns 46,162 shares of the medical equipment provider’s stock valued at $1,811,000 after buying an additional 1,522 shares during the last quarter. State Street Corp boosted its stake in shares of Natus Medical by 8.5% in the first quarter. State Street Corp now owns 810,658 shares of the medical equipment provider’s stock valued at $31,823,000 after buying an additional 63,493 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. bought a new stake in shares of Natus Medical during the first quarter valued at $309,000. 92.47% of the stock is currently owned by institutional investors.

BABY has been the topic of several recent research reports. Benchmark Co. reiterated a “buy” rating and set a $48.00 price objective (down from $55.00) on shares of Natus Medical in a research report on Monday, May 1st. TheStreet lowered Natus Medical from a “b” rating to a “c+” rating in a research report on Thursday, April 27th. Finally, Zacks Investment Research upgraded Natus Medical from a “sell” rating to a “hold” rating in a research report on Tuesday, April 4th. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and one has issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $45.00.

Natus Medical Company Profile

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:BABY”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for Natus Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
President Trump Hurting Tourism in the U.S.
President Trump Hurting Tourism in the U.S.
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Blue Apron Filed Thursday for Public Offering
Blue Apron Filed Thursday for Public Offering
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Large Auto Lender Checked Just 8% of Incomes for Applicants
Large Auto Lender Checked Just 8% of Incomes for Applicants


Leave a Reply

© 2006-2017 Ticker Report. Google+.